Dr Matthew Aaron Cavagnaro, MD | |
295 Essjay Rd, Williamsville, NY 14221-8216 | |
(716) 908-2221 | |
Not Available |
Full Name | Dr Matthew Aaron Cavagnaro |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 15 Years |
Location | 295 Essjay Rd, Williamsville, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841424439 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XX0005X | Orthopaedic Surgery - Sports Medicine | 280817 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Vna Of Western Ny Chha | Williamsville, NY | Home health agency |
Mcauley Seton Home Care Corp Chha | Buffalo, NY | Home health agency |
Kaleida Health | Buffalo, NY | Hospital |
Kenmore Mercy Hospital | Kenmore, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Buffalo Medical Group, P.c. | 7012820301 | 230 |
News Archive
Bariatric surgery is significantly safer when performed at an accredited center, according to new research presented here at the 30th Annual Meeting for the American Society for Metabolic and Bariatric Surgery during ObesityWeek 2013, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The event is hosted by the ASMBS and The Obesity Society.
University of Cincinnati (UC) researchers have discovered a gene that helps control the secretion of acid in the stomach - information that could one day aid scientists in creating more efficient treatment options for conditions such as acid reflux or peptic ulcers.
The drive toward containing health care costs could have the unintended consequence of reducing physician productivity, impairing quality and perhaps even increasing costs, two Beth Israel Deaconess Medical Center physicians suggest in a New England Journal of Medicine "Perspective."
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
"This year marks the 10th anniversary of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the world's most powerful tool in the fight against the three pandemics," Jonathan Klein, co-founder and CEO of Getty Images, Inc., writes in this post in the Huffington Post Blog.
› Verified 8 days ago
Entity Name | Buffalo Medical Group, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881659506 PECOS PAC ID: 7012820301 Enrollment ID: O20031112000213 |
News Archive
Bariatric surgery is significantly safer when performed at an accredited center, according to new research presented here at the 30th Annual Meeting for the American Society for Metabolic and Bariatric Surgery during ObesityWeek 2013, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The event is hosted by the ASMBS and The Obesity Society.
University of Cincinnati (UC) researchers have discovered a gene that helps control the secretion of acid in the stomach - information that could one day aid scientists in creating more efficient treatment options for conditions such as acid reflux or peptic ulcers.
The drive toward containing health care costs could have the unintended consequence of reducing physician productivity, impairing quality and perhaps even increasing costs, two Beth Israel Deaconess Medical Center physicians suggest in a New England Journal of Medicine "Perspective."
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
"This year marks the 10th anniversary of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the world's most powerful tool in the fight against the three pandemics," Jonathan Klein, co-founder and CEO of Getty Images, Inc., writes in this post in the Huffington Post Blog.
› Verified 8 days ago
Entity Name | Millard Fillmore Surgery Center, Llc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1689852618 PECOS PAC ID: 2466500533 Enrollment ID: O20090429000161 |
News Archive
Bariatric surgery is significantly safer when performed at an accredited center, according to new research presented here at the 30th Annual Meeting for the American Society for Metabolic and Bariatric Surgery during ObesityWeek 2013, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The event is hosted by the ASMBS and The Obesity Society.
University of Cincinnati (UC) researchers have discovered a gene that helps control the secretion of acid in the stomach - information that could one day aid scientists in creating more efficient treatment options for conditions such as acid reflux or peptic ulcers.
The drive toward containing health care costs could have the unintended consequence of reducing physician productivity, impairing quality and perhaps even increasing costs, two Beth Israel Deaconess Medical Center physicians suggest in a New England Journal of Medicine "Perspective."
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
"This year marks the 10th anniversary of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the world's most powerful tool in the fight against the three pandemics," Jonathan Klein, co-founder and CEO of Getty Images, Inc., writes in this post in the Huffington Post Blog.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Matthew Aaron Cavagnaro, MD 425 Essjay Rd Ste 170, Williamsville, NY 14221-8235 Ph: (716) 630-1219 | Dr Matthew Aaron Cavagnaro, MD 295 Essjay Rd, Williamsville, NY 14221-8216 Ph: (716) 908-2221 |
News Archive
Bariatric surgery is significantly safer when performed at an accredited center, according to new research presented here at the 30th Annual Meeting for the American Society for Metabolic and Bariatric Surgery during ObesityWeek 2013, the largest international event focused on the basic science, clinical application and prevention and treatment of obesity. The event is hosted by the ASMBS and The Obesity Society.
University of Cincinnati (UC) researchers have discovered a gene that helps control the secretion of acid in the stomach - information that could one day aid scientists in creating more efficient treatment options for conditions such as acid reflux or peptic ulcers.
The drive toward containing health care costs could have the unintended consequence of reducing physician productivity, impairing quality and perhaps even increasing costs, two Beth Israel Deaconess Medical Center physicians suggest in a New England Journal of Medicine "Perspective."
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
"This year marks the 10th anniversary of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the world's most powerful tool in the fight against the three pandemics," Jonathan Klein, co-founder and CEO of Getty Images, Inc., writes in this post in the Huffington Post Blog.
› Verified 8 days ago
Keith Charles Stube, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 180 Park Club Ln Ste 225, Williamsville, NY 14221 Phone: 716-839-5858 | |
Dr. Anthony Michael Leone, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 192 Park Club Ln, Suite 120, Williamsville, NY 14221 Phone: 716-667-7463 Fax: 716-276-8356 | |
Robert K Brown, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 192 Park Club Ln, Suite 100, Williamsville, NY 14221 Phone: 716-204-1101 Fax: 716-204-0914 | |
Dr. Daniel R Wild, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 425 Essjay Rd, Suite 170a, Williamsville, NY 14221 Phone: 716-631-3041 Fax: 716-631-5380 | |
Dr. Lindsay Rose Kosinski, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 N Maplemere Rd Ste 100, Williamsville, NY 14221 Phone: 716-204-3200 Fax: 716-204-4337 | |
Dr. Joseph P Falcone, M.D., D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Spindrift Dr, Suite 120, Williamsville, NY 14221 Phone: 716-632-1212 Fax: 716-632-3012 | |
Dr. Walter D Hoffman, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 192 Park Club Lane Suite 100, Williamsville, NY 14221 Phone: 716-204-1101 Fax: 716-204-0914 |